scientific program • symposia - American Society for Reproductive ...

P-324 SUSHI DOMAIN CONTAINING 3 (SUSD3) AND ITS ROLE
IN BREAST CANCER CELL MORPHOLOGY, MIGRATION, AND
ADHESION.
I. Moy 1 , V. Todorovic 2 , K. J. Green 2 , S. E. Bulun 1 . 1 Division of
Reproductive Biology Research, Northwestern Feinberg School of
Medicine, Chicago, IL; 2 Department of Pathology, Northwestern
Feinberg School of Medicine, Chicago, IL.
P-325 THE IMPACT OF CHEMOTHERAPY ON IVF OUTCOMES.
M. Karsy 1,2 , E. Arslan 1 , F. Moy 1,2 , K. Oktay 1 . 1 Department of Obstetrics
& Gynecology, Institute for Fertility Preservation, New York Medical
College, Valhalla, NY; 2 Department of Pathology, New York Medical
College, Valhalla, NY.
__________________________________________________________
FERTILITY PRESERVATION
P-326 THE USE OF LETROZOLE IN BREAST CANCER PATIENTS
UNDERGOING FERTILITY PRESERVATION IVF TREATMENT IS
ASSOCIATED WITH SIMILAR OOCYTE YIELD AND REDUCED
ESTRADIOL LEVELS.
T. Singer, J. Huang, L. Zakarin, J. Lekovic-Bijelic, S. D. Spandorfer, G.
L. Schattman. The Center for Reproductive Medicine and Infertility,
Weill Cornell Medical College, New York, NY.
P-327 COMPARISON OF FOUR DIFFERENT CRYOPROTECTANT
COMBINATIONS TO OBTAIN OPTIMAL OOCYTE SURVIVAL AND
EMBRYO DEVELOPMENT IN A MOUSE MODEL.
C.-C. Chang 1 , C.-J. Lin 2 , X. C. Tian 2 , A. A. Toledo 1 , D. Mitchell-Leef 1 , Z.
P. Nagy 1 . 1 Reproductive Biology Associates, Atlanta, GA; 2 University
of Connecticut, Storrs, CT.
P-328 PATIENT-REPORTED BARRIERS TO FERTILITY
PRESERVATION.
J. M. Letourneau 1 , J. F. Smith 2 , P. Katz 3 . 1 Obstetrics, Gynecology and
Reproductive Sciences, University of California, San Francisco, San
Francisco, CA; 2 Department of Urology, University of California, San
Francisco, San Francisco, CA; 3 Department of Medicine, University
of California, San Francisco, San Francisco, CA.
P-329 LATE STAGED BREAST CANCER PATIENTS DESIRE
CHILDREN AFTER CANCER YET FEW HAVE THEIR DESIRES
ASSESSED BY ONCOLOGISTS WHEN COMPARED TO WOMEN
WITH EARLY STAGED DISEASE.
E. Ebbel, J. Letourneau, C.-N. Kao, M. Rosen. Obstetrics,
Gynecology and Reproductive Sciences, University of California,
San Francisco, San Francisco, CA.
P-330 TRACKING THE DEVELOPMENT POTENTIAL AND
THE ONSET INHIBITION OF PRIMORDIAL FOLLICLE OF THE
CRYOPRESERVED MURINE OVARY WITH BIOLUMINESCENT
IMAGING (BLI) IN VIVO.
C.-H. Chen 1 , C.-R. Tzeng 1 , C.-W. Wang 1 , M.-I. Hsu 2 . 1 Center for
Reproductive Medicine & Sciences, Taipie Medical University
Hospital, Taipei, Taiwan; 2 Department of Obstetrics & Gynecology,
Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
P-331 GLIAL-DERIVED NEUROTROPHIC FACTOR PROMOTES
HUMAN OVARIAN PRIMORDIAL FOLLICLE DEVELOPMENT.
F. Dong, Y. Sun, X. Liu, L. Ma, Y. Su, Y. Guo. Center for Reproductive
Medical, The First Affiliated Hospital of Zhengzhou University,
Zhengzhou, Henan, China.
P-332 OVARIAN RESERVE AND RESPONSE TO IN-VITRO-
FERTILIZATION AND IN-VITRO-MATURATION TREATMENTS
FOLLOWING CHEMOTHERAPY.
M. Das, W.-Y. Son, H. Holzer, T. Tulandi. McGill Reproductive Center,
Department of Obstetrics and Gynecology, McGill University,
Montreal, QC, Canada.
P-333 BIOLUMINESCENCE IMAGING (BLI) AS A TOOL TO
EVALUATE GERM CELL IN VITRO AND TRANSPLANTATION IN
VIVO AS FERTILITY PRESERVATION OF PREPUBERTAL MALE MICE.
C.-H. Chen 1 , C.-R. Tzeng 1 , C.-W. Wang 1 , M.-I. Hsu 2 . 1 Center for
Reproductive Medicine & Sciences, Taipei Medical University
POSTER PRESENTATIONS
157
Hospital, Taipei, Taiwan; 2Department of Obstetrics & Gynecology,
Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
P-334 EFFECT OF GYNECOLOGIC SURGERY FOR BENIGN
DISEASE ON OVARIAN RESERVE IN EARLY POSTOPERATIVE
PERIOD: COMPARISON BETWEEN PRE- AND POSTOPERATIVE
SERUM ANTI-MULLERIAN HORMONE LEVEL.
S. Chun1 , Y. I. Ji1 , Y. H. Koo2 , G. H. Jeon1 , H. J. Cho1 . 1Obstetrics and
Gynecology, Inje University Haeundae Paik Hospital, Busan, Korea;
2Obstetrics and Gynecology, Pusan National University Yangsan
Hospital, Yangsan, Gyungsangnam-do, Korea.
P-335 FERTILITY PRESERVATION ATTITUDES AND PRACTICE
SURVEY ADMINISTERED TO ONCOLOGY PROVIDERS AT THE
UNIVERSITY OF COLORADO (UC).
D. M. Itani 1 , J. Lomax 1 , C. McBreen 2 , L. Blyth 1 , J. Manheimer 1 , W.
Schlaff 1 . 1 OB GYN, University of Colorado Denver, Aurora, CO;
2 University of Colorado Hospital, Aurora, CO.
P-336 FERTILITY PRESERVATION: IVF OUTCOMES MAY DIFFER
BY CANCER DIAGNOSIS.
J. E. Hirshfeld-Cytron, M. E. Pavone, R. R. Kazer, S. Klock. Obstetrics
and Gynecology, Northwestern University, Feinberg School of
Medicine, Chicago, IL.
P-337 A NEW CRYOMEDIA WITHOUT ANIMAL COMPONENTS
FOR FERTILITY PRESERVATION IN MEN: MOTILITY AND VARIOUS
ATTRIBUTES AFFECTING PATERNAL CONTRIBUTION OF SPERM.
M. Tekcan, L. Sati, W. Murk, J. Stronk, G. Huszar. Yale University School
of Medicine, New Haven, CT.
P-338 PROTEOMIC PROFILE AND FUNCTIONAL ENRICHMENT
OF GENE ONTOLOGY TERMS IN MEN WITH TESTICULAR
CANCER.
D. S. Tibaldi, C. Sposito, P. T. Del Giudice, R. M. Fariello, D. Spaine, R.
Fraietta. Urology, Federal University of Sao Paulo, Sao Paulo, Brazil.
P-339 PSYCHOLOGY OF EGG FREEZING PATIENTS: WOULD
THEY CONSIDER SINGLE MOTHERHOOD?
L. Schuman 1 , G. Witkin 1,2 , K. Copperman 1 , M. Acosta-La Greca 1 .
1 Reproductive Medicine Associates of New York, New York, NY;
2 Department of OBGYN and Reproductive Science, Mount Sinai
School of Medicine, New York, NY.
P-340 FERTILITY PRESERVATION: ARE WE DOING ENOUGH
FOR PATIENTS UNDERGOING ONCOLOGY TREATMENT?
N. Potdar 1 , A. Lewis-Evans 1 , C. Freeman 2 , J. Blower 2 , S. Vitthala 2 ,
J. Elson 2 . 1 Reproductive Sciences Section, University of Leicester,
Leicester, Leicestershire, United Kingdom; 2 University Hospitals of
Leicester, Leicester, Leicestershire, United Kingdom.
P-341 DEATH AND POSTHUMOUS REPRODUCTION IN THE
SETTING OF FERTILITY PRESERVATION.
R. P. Gada, A. L. Brien, P. H. Leonard, H. S. Wolff, J. R. Jensen.
Reproductive Endocrinology and Infertility, Mayo Clinic, Rochester,
MN.
__________________________________________________________
CRYOPRESERVATION
P-342 DEVELOPMENT OF A MICROFLUIDIC DEVICE FOR
AUTOMATED VITRIFICATION HUMAN EMBRYO.
L. Meng1 , X. Huezo2 , B. A. Stone1 , K. Baek1 , G. Ringler1 , R. P.
Marrs1 . 1California Fertility Partners, Los Angeles, CA; 2Mariposa Biotechnology, Inc, San Clemente, CA.
P-343 FREEZING HAS NO NEGATIVE IMPACT ON THE
IMPLANTATION POTENTIAL OF TOP QUALITY EMBRYOS.
Z. Veleva, H. Martikainen. Ob/Gyn, Oulu University Hospital, Oulu,
Finland.
P-344 ARTIFICIAL COLLAPSE OF BLASTOCYSTS AND LASER
ASSISTED HATCHING CAN IMPROVE CLINICAL PREGNANCY
OUTCOMES WITH BLASTOCYST STAGE VITRIFICATION.
N. Desai, F. AbdelHafez, J. Goldberg, C. Austin. OB-GYN/Women’s
Health Institute, Cleveland Clinic/Fertility Center, Beachwood, OH.